Hepatitis B virus infection

Related records

Broader conditions (18)

• Digestive system disorder
• Digestive system infectious disorder
• Disease
• Disease by body system or component
• Disease by developmental or physiological process
• Disease by etiologic mechanism
• Disease of primarily extrinsic mechanism
• Endocrine system disorder
• Hepadnaviridae infectious disease
• Hepatitis
• Hepatobiliary disorder
• Human disease
• Infectious disease
• Inflammatory disease
• Liver disorder
• Primary viral infectious disease
• Viral hepatitis
• Viral infectious disease

Narrower conditions (2)

• Acute hepatitis B virus infection
• Chronic hepatitis B virus infection

Trials (1,469)

• 'Tenofovir Pulse and Peg Interferon Alpha 2b' Therapy in HBeAg-positive Patients With Normal ALT
• "Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma
• "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
• "HBV unIversal vs Point-Of-Care-based Antiviral treatMent to Prevent Mother-to-child Transmission"
• "Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection
• 3E Extension Study
• 4-Methylumbelliferone as a Treatment for Chronic HBV/HCV
• 48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection
• A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.
• A Bridging Study: Comparing Two Lots of Sci-B-Vac™ and Engerix-B in Healthy Adults
• A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial
• A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
• A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B
• A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection
• A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection
• A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B
• A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects
• A Clinical Trial of TQA3038 Injection in Healthy Adult Subjects
• A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant
• A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB

Approved drugs (13)

• Adefovir dipivoxil
• Entecavir
• Hepatitis B immune globulin
• Hepatitis B virus hbsag surface protein antigen
• Hepatitis B virus S protein, pre-S1 protein and pre-S2 protein virus like particles
• Interferon alfa-2B
• Lamivudine
• Peginterferon alfa-2A
• Telbivudine
• Tenofovir alafenamide fumarate
• Tenofovir disoproxil fumarate
• Tenofovir disoproxil maleate
• Tenofovir disoproxil phosphate

Drugs in development (68)

• 1018 ISS Phase 2
• Acetaminophen Phase 1
• Adefovir Phase 3
• Alendronic acid Phase 1
• Amdoxovir Phase 2
• Antroquinonol Phase 2
• Bepirovirsen Phase 3
• Bepirovirsen sodium Phase 1
• Bersacapavir Phase 2
• Birinapant Phase 1
• Bulevirtide Phase 2
• Carbamazepine Phase 1
• Cemiplimab Phase 1
• Clevudine Phase 3
• Daclatasvir Phase 2
• Daplusiran Phase 1
• Dasabuvir Phase 2
• Detiviciclovir Phase 2
• Elebsiran Phase 2
• Emtricitabine Phase 3

Other linked drugs (11)

• Bordetella pertussis filamentous hemagglutinin
• Bordetella pertussis pertactin autotransporter
• Diphtheria toxoid
• Elvucitabine
• Ergocalciferol
• Interferon
• Metformin
• Peginterferon alfa-2B
• Prednisone
• Tetanus toxoid
• Tuvirumab